Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation
暂无分享,去创建一个
K. Morimura | F. Gonzalez | Qian Yang | Y. Shah | T. Tanabe | M. Takagi
[1] F. Gonzalez,et al. Hepatocyte-restricted constitutive activation of PPAR alpha induces hepatoproliferation but not hepatocarcinogenesis. , 2007, Carcinogenesis.
[2] T. Willson,et al. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. , 2007, Molecular cell.
[3] A. Hatzigeorgiou,et al. A guide through present computational approaches for the identification of mammalian microRNA targets , 2006, Nature Methods.
[4] Fei Li,et al. Primary transcripts and expressions of mammal intergenic microRNAs detected by mapping ESTs to their flanking sequences , 2006, Mammalian Genome.
[5] Clifford A. Meyer,et al. Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.
[6] E. Furth,et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster , 2006, Nature Genetics.
[7] Harvey F Lodish,et al. Myogenic factors that regulate expression of muscle-specific microRNAs. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[8] Anindya Dutta,et al. MicroRNAs: small but potent oncogenes or tumor suppressors. , 2006, Current opinion in investigational drugs.
[9] J. Ward,et al. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. , 2006, Carcinogenesis.
[10] W. Wahli,et al. Transcriptional regulation of metabolism. , 2006, Physiological reviews.
[11] Ligang Wu,et al. MicroRNAs direct rapid deadenylation of mRNA. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[12] G. Hannon,et al. Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.
[13] Olga Varlamova,et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[15] Chang-Zheng Chen,et al. MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.
[16] Amir Gamliel,et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ , 2005, Nature.
[17] Richard T. Miller,et al. Evaluation of the Carcinogenic Potential of Clofibrate in the FVB/Tg.AC Mouse After Dermal Application—Part II , 2005 .
[18] Richard T. Miller,et al. Evaluation of the Carcinogenic Potential of Clofibrate in the rasH2 Mouse , 2005, International journal of toxicology.
[19] Richard T. Miller,et al. Evaluation of the Carcinogenic Potential of Clofibrate in FVB/Tg.AC Mouse After Oral Administration—Part I , 2005, International journal of toxicology.
[20] A. Pasquinelli,et al. Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.
[21] Yong Zhao,et al. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.
[22] Frank J. Gonzalez,et al. Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand? , 2005, Journal of Molecular Medicine.
[23] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[24] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[25] F. Slack,et al. RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.
[26] Wayne Tam,et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Cullen,et al. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. , 2004, RNA.
[28] R. Shiekhattar,et al. The Microprocessor complex mediates the genesis of microRNAs , 2004, Nature.
[29] J. M. Thomson,et al. Argonaute2 Is the Catalytic Engine of Mammalian RNAi , 2004, Science.
[30] T. Tuschl,et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. , 2004, Molecular cell.
[31] J. Ward,et al. Diminished Hepatocellular Proliferation in Mice Humanized for the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α , 2004, Cancer Research.
[32] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[33] A. Baniahmad,et al. Gene repression by nuclear hormone receptors. , 2004, Essays in biochemistry.
[34] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[35] John G Doench,et al. Specificity of microRNA target selection in translational repression. , 2004, Genes & development.
[36] Tetsuya Suga,et al. Hepatocarcinogenesis by peroxisome proliferators. , 2004, Journal of Toxicological Sciences.
[37] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[38] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[39] Channing J Der,et al. The dark side of Ras: regulation of apoptosis , 2003, Oncogene.
[40] Michael Z Michael,et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. , 2003, Molecular cancer research : MCR.
[41] Kathryn A. O’Donnell,et al. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets , 2003, Genome Biology.
[42] Itaru Matsumura,et al. E2F1 and c-Myc in Cell Growth and Death , 2003, Cell cycle.
[43] J. McCubrey,et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). , 2003, International journal of oncology.
[44] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] V. Kim,et al. MicroRNA maturation: stepwise processing and subcellular localization , 2002, The EMBO journal.
[46] T. Tuschl,et al. Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.
[47] V. Ambros. microRNAs Tiny Regulators with Great Potential , 2001, Cell.
[48] J. Reddy,et al. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. , 2000, Mutation research.
[49] J. Peters,et al. Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated Receptor α , 1998 .
[50] J. Peters,et al. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. , 1997, Carcinogenesis.
[51] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[52] T. Goldsworthy,et al. Expression of myc, fos and Ha‐ras associated with chemically induced cell proliferation in the rat liver , 1994, Cell proliferation.
[53] S Kettle,et al. Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.
[54] S. Thorgeirsson,et al. Transgenic Mouse Model for Synergistic Effects of Nuclear Oncogenes and Growth Factors in Tumorigenesis: Interaction of c-myc and Transforming Growth Factor α in Hepatic Oncogenesis , 1993 .
[55] N. Latruffe,et al. Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators. , 1990, Biochemical and biophysical research communications.
[56] B. Vogelstein,et al. RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study , 1990, Genes, chromosomes & cancer.
[57] Y. Nakamura,et al. Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.
[58] J. Reddy,et al. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens , 1980, Nature.
[59] F. McCormick,et al. Cancer targets in the Ras pathway. , 2005, Cold Spring Harbor symposia on quantitative biology.
[60] Shioko Kimura,et al. Microarray analysis using amplified mRNA from laser capture microdissection of microscopic hepatocellular precancerous lesions and frozen hepatocellular carcinomas reveals unique and consistent gene expression profiles. , 2003, Toxicologic pathology.
[61] I. Jonkers,et al. Hypertriglyceridemia , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[62] A. Van der Laarse,et al. Hypertriglyceridemia: associated risks and effect of drug treatment. , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[63] J. Peters,et al. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. , 1998, Journal of the National Cancer Institute.
[64] B E Butterworth,et al. A decision tree approach for carcinogen risk assessment. , 1995, Progress in clinical and biological research.
[65] S. Thorgeirsson,et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. , 1993, Cancer research.
[66] B. Vogelstein,et al. Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.